These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16859410)

  • 41. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
    Usmani KA; Karoly ED; Hodgson E; Rose RL
    Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of drug-drug interaction for silymarin.
    Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
    Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam.
    Senda C; Kishimoto W; Sakai K; Nagakura A; Igarashi T
    Xenobiotica; 1997 Sep; 27(9):913-22. PubMed ID: 9381732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes.
    Olesen OV; Linnet K
    Pharmacology; 1997 Nov; 55(5):235-43. PubMed ID: 9399333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities.
    Dixit V; Hariparsad N; Desai P; Unadkat JD
    Biopharm Drug Dispos; 2007 Jul; 28(5):257-62. PubMed ID: 17443647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery.
    Bell L; Bickford S; Nguyen PH; Wang J; He T; Zhang B; Friche Y; Zimmerlin A; Urban L; Bojanic D
    J Biomol Screen; 2008 Jun; 13(5):343-53. PubMed ID: 18474896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s.
    Chen ZH; Zhang SX; Long N; Lin LS; Chen T; Zhang FP; Lv XQ; Ye PZ; Li N; Zhang KZ
    Acta Pharmacol Sin; 2016 May; 37(5):708-18. PubMed ID: 27063220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.
    Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
    Biochem Pharmacol; 1996 Oct; 52(8):1305-9. PubMed ID: 8937439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes.
    Ishiguro N; Senda C; Kishimoto W; Sakai K; Funae Y; Igarashi T
    Xenobiotica; 2000 Jan; 30(1):71-80. PubMed ID: 10659952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
    Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
    Lang J; Li W; Zhao J; Wang K; Chen D
    Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
    Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
    Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
    Kudo S; Odomi M
    Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.